Physiologically based pharmacokinetic model for the renal clearance of salicyluric acid and the interaction with phenolsulfonphthalein in the dog
- PMID: 2891488
Physiologically based pharmacokinetic model for the renal clearance of salicyluric acid and the interaction with phenolsulfonphthalein in the dog
Abstract
Plasma kinetics and renal excretion of salicyluric acid (SUA, 0.8 g) administered iv, with and without concomitant administration of phenolsulfonphthalein (PSP), were studied in the beagle dog. Pharmacokinetic analysis revealed that tubular secretion is the predominant route of excretion, and that secretion is inhibited by PSP. A physiologically based kidney model is presented comprising all the functional characteristics of the kidney that determine the excretion of SUA, i.e. renal plasma flow, urine flow, nonlinear protein binding, glomerular filtration, tubular secretion, and tubular accumulation. The model enabled an accurate description and analysis of the measured plasma levels and renal excretion rates. The interaction with PSP could be adequately described with the model by noncompetitive inhibition of the carrier-mediated uptake of SUA into the tubular cells. Furthermore, a small but significant reduction in nonrenal SUA clearance was observed. Model calculations showed that, in the control experiments, tubular secretion was accompanied by a pronounced accumulation of SUA within the cells, which was clearly diminished in the presence of PSP. The predicted accumulation ratios were in good agreement with previously reported in vitro values.
Similar articles
-
Physiologically based pharmacokinetic model for the renal clearance of phenolsulfonphthalein and the interaction with probenecid and salicyluric acid in the dog.J Pharmacokinet Biopharm. 1987 Aug;15(4):349-68. doi: 10.1007/BF01066518. J Pharmacokinet Biopharm. 1987. PMID: 3681664
-
Physiologically based pharmacokinetic model for the renal clearance of iodopyracet and the interaction with probenecid in the dog.Biopharm Drug Dispos. 1989 Mar-Apr;10(2):137-52. doi: 10.1002/bdd.2510100204. Biopharm Drug Dispos. 1989. PMID: 2706315
-
Renal clearance of substituted hippurates in the dog. II. 4-Amino-, hydroxy- and methoxy-substituted benzoylglycines.J Pharmacol Exp Ther. 1989 Jan;248(1):436-46. J Pharmacol Exp Ther. 1989. PMID: 2913287
-
Prediction of human pharmacokinetics - renal metabolic and excretion clearance.J Pharm Pharmacol. 2007 Nov;59(11):1463-71. doi: 10.1211/jpp.59.11.0002. J Pharm Pharmacol. 2007. PMID: 17976256 Review.
-
Renal clearance parameters for PBPK model analysis of early lifestage differences in the disposition of environmental toxicants.Regul Toxicol Pharmacol. 2008 Jun;51(1):66-86. doi: 10.1016/j.yrtph.2008.02.005. Epub 2008 Feb 29. Regul Toxicol Pharmacol. 2008. PMID: 18433959 Review.
Cited by
-
A physiological model for renal drug metabolism: enalapril esterolysis to enalaprilat in the isolated perfused rat kidney.J Pharmacokinet Biopharm. 1990 Dec;18(6):561-87. doi: 10.1007/BF01073939. J Pharmacokinet Biopharm. 1990. PMID: 2177788
-
Saturable pharmacokinetics in the renal excretion of drugs.Clin Pharmacokinet. 1989 Jan;16(1):38-54. doi: 10.2165/00003088-198916010-00003. Clin Pharmacokinet. 1989. PMID: 2650954 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous